Radiopharm Theranostics products

Nano-mAbs is the invention of Dr Hong Hoi Ting, an internationally regarded radiopharmaceutical and nuclear medicine expert, formerly from the University of Oxford.

Pivalate is the invention of Professor Eric Aboagye of Imperial College London: Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate which utilises the early steps of fatty acid oxidation and is very stable; In comparison to the clinical standard in PET imaging, 18F-FDG in prostate and brain cancers, Pivalate showed superior imaging performance and was equally good for two breast cancer models.

PSA-mAb is the invention of Professor David Ulmert formerly of Memorial Sloan Kettering and now UCLA.

DUNP19 is the invention of Professor Ulmert at UCLA.

PTPµ (PTPmu) is a peptide molecule biomarker, invented by Dr Susann Brady-Kalnay at Case Western Reserve University in Ohio.